← All trials
NCT04551131
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2021
- Primary completion
- Aug 31, 2025
- Completion date
- Aug 31, 2026
- First posted
- Sep 16, 2020
- Last posted
- Dec 28, 2020
- Enrollment
- 62
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- St. Jude Children's HospitalLead sponsor
- IncyteCollaborator
- St. Jude Children's HospitalStudy chair
- North American Consortium for HistiocytosisCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.